Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II. | Cancers (Basel) | 2020 | 33027952 | PubTator, text mining | PubMed |
| TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. | BMC Cancer | 2020 | 33023532 | PubTator, text mining | PubMed |
| Role of Post-translational Modifications in Influenza A Virus Life Cycle and Host Innate Immune Response. | Front Microbiol | 2020 | 33013775 | PubTator, text mining | PubMed |
| Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases. | Exp Mol Med | 2020 | 33005013 | PubTator, text mining | PubMed |
| Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment. | Cancers (Basel) | 2020 | 33003469 | PubTator, text mining | PubMed |
Inhibition mechanism of naphthylphenylamine derivatives acting on the CDC25B dual phosphatase and analysis of the molecular processes involved in the high cytotoxicity exerted by one selected derivative in melanoma cells. | J Enzyme Inhib Med Chem | 2020 | 32990107 | PubTator, text mining | PubMed |
| Mechanisms Underlying Biological Effects of Cruciferous Glucosinolate-Derived Isothiocyanates/Indoles: A Focus on Metabolic Syndrome. | Front Nutr | 2020 | 32984393 | PubTator, text mining | PubMed |
| Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer. | Nat Commun | 2020 | 32978398 | PubTator, text mining | PubMed |
| MiRNA Profiles of Extracellular Vesicles Secreted by Mesenchymal Stromal Cells-Can They Predict Potential Off-Target Effects? | Biomolecules | 2020 | 32971982 | PubTator, text mining | PubMed |
| The Role of Chaperone-Mediated Autophagy in Cell Cycle Control and Its Implications in Cancer. | Cells | 2020 | 32971884 | PubTator, text mining | PubMed |
| FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery. | Cells | 2020 | 32961751 | PubTator, text mining | PubMed |
| Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. | Exp Hematol | 2020 | 32946981 | PubTator, text mining | PubMed |
| LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers. | Biomark Res | 2020 | 32944244 | PubTator, text mining | PubMed |
| Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines. | Biomed Rep | 2020 | 32934816 | PubTator, text mining | PubMed |
| GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer. | Onco Targets Ther | 2020 | 32922038 | PubTator, text mining | PubMed |
| Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation. | J Hematol Oncol | 2020 | 32883316 | PubTator, text mining | PubMed |
| Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma. | Elife | 2020 | 32880368 | PubTator, text mining | PubMed |
| Pathogenic impact of transcript isoform switching in 1,209 cancer samples covering 27 cancer types using an isoform-specific interaction network. | Sci Rep | 2020 | 32879328 | PubTator, text mining | PubMed |
| Covalent inhibition of NSD1 histone methyltransferase. | Nat Chem Biol | 2020 | 32868895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=30